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Alteration of Immune Responses by
N-acetylglucosaminyltransferase V
during Allergic Airway Inflammation
Akiko Shibui1,4, Aya Nambu2,6, Eri Shimura2, Sachiko Yamaguchi3, Chiharu Shiraishi4,
Yoshitaka Sato4, Ko Okumura2, Sumio Sugano1, Nobumichi Hozumi4,5 and Susumu Nakae3,6
ABSTRACT
Background: β-1,6-N-acetylglucosaminyltransferase V (Mgat5 or GlcNac-TV), which is involved in the glyco-
sylation of proteins, is known to be important for down-regulation of TCR-mediated T-cell activation and nega-
tively regulates induction of contact dermatitis and experimental autoimmune encephalomyelitis. However, the
role of Mgat5 in the induction of allergic airway inflammation remains unclear.
Methods: To elucidate the role of Mgat5 in the pathogenesis of allergic airway inflammation, ovalbumin
(OVA)-induced airway inflammation was induced in Mgat5-deficient mice. The OVA-specific lymphocyte prolif-
eration and cytokine production levels, OVA-specific IgG1, IgG2a and IgE levels in the serum, and the number
of leukocytes and cytokine levels in the bronchoalveolar lavage (BAL) fluid were compared between wild-type
and Mgat5-deficient mice.
Results: OVA-specific lymphocyte proliferation and production of IFN-γ and IL-10, but not IL-4, were increased
in Mgat5-deficient mice, suggesting that Th2-type immune responses are seemed to be suppressed by in-
creased IFN-γ and IL-10 production in these mice. However, Th2-type responses such as OVA-specific IgG1,
but not IgE, and IL-5 levels in BAL fluids were increased in Mgat5-deficient mice. Meanwhile, the number of
eosinophils was normal, but the numbers of neutrophils, macrophages and lymphocytes were reduced, in
these mutant mice during OVA-induced airway inflammation.
Conclusions: Mgat5-dependent glycosylation of proteins can modulate acquired immune responses, but it is
not essential for the development of OVA-induced eosinophilic airway inflammation.
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INTRODUCTION
Glycosylation of proteins in mammals is important for
the pathophysiological function of the proteins and
contributes to the maintenance of homeostasis in the
whole body.1-3 Indeed, the lack of certain glycosyla-
tion pathways leads to abnormalities of development
andor growth, leukocyte trafficking and adhesion in
mice.4,5 Glycosylated proteins, or “glycoproteins,” are
divided into two groups, i.e., N-glycoproteins and O-
glycoproteins, according to the patterns of the bonds
between sugar chains and proteins.3 N-glycoproteins
are further divided into 3 types: high-mannose-type,
hybrid-type and complex-type.1 β-1,6-N-acetylgluco-
saminyltransferase V (Mgat5 or GlcNac-TV), which is
present in the medial golgi of cells, is involved in the
synthesis of complex-type N-glycoproteins by adding
N-acetylglucosamine to a mannose of trimannose via
a β-1,6 bond.6 Mice deficient in β-1,6-N-acetylgluco-
saminyltransferase V (Mgat5-- mice) are fertile and
born at the expected Mendelian ratio without any
gross abnormalities,6 but these mutant mice show ab-
normalities of behavior, i.e. , parenting and
depression-like phenotypes on the 129 x PLJ and
C57BL6 backgrounds, respectively.6,7
In T cells, the TCRα and β chains and the CD3α
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and δ chains, which have 7 and 1 potential Mgat5 N-
glycosylation sites, respectively, are considered to be
complex-type N-glycoproteins.8 Mgat5-modified gly-
cans are further extended with N-acetyllactosamine.9
Galectin-3, which is a member of a widely expressed
family of lectins in mammals known as N-
acetyllactosamine-binding proteins, binds to TCRs to
form a lattice structure that results in down-
regulation of TCR engagements with the antigen
MHC class II complex.10 Therefore, T cells from
Mgat5-- mice showed hypersensitivity in response to
anti-TCR agonistic mAb accompanied by increased
TCR clustering and immunosynapse formation,10 po-
tentiated intracellular signal transduction10 and ex-
cessive Th1 cytokine production.11 Those findings
suggest that Mgat5 is involved in the induction of T-
cell-mediated acquired immune responses. Further
supporting that, Mgat5-- mice spontaneously devel-
oped autoimmune kidney glomerulonephritis.10 In ad-
dition, the development of T-cell-mediated allergic
disorders such as contact dermatitis and autoimmune
diseases such as experimental autoimmune encepha-
lomyelitis was exacerbated in Mgat5-- mice,10 indicat-
ing that Mgat5 is crucial for the development of T-
cell-mediated immune responses. On the other hand,
although the involvement of Mgat5 in the develop-
ment of such disorders has been demonstrated, the
role of Mgat5 in Th2-cytokine-associated immune re-
sponses such as allergic asthma remains unclear.
Therefore, in the present study, we investigated the
role of Mgat5 in the development of allergic airway
inflammation using Mgat5-- mice on the BALBc
background.
METHODS
MICE
BALBcA mice were purchased from Japan SLC (Shi-
zuoka, Japan). Mgat5-- mice12 on a BALBc back-
ground were produced by crossing Mgat5-- C57BL6
mice with BALBc mice for more than six genera-
tions. DO11.10 mice13 were kindly provided by Dr.
Masato Kubo (Tokyo University of Science). The
mice were housed under specific-pathogen-free con-
ditions at The Institute of Medical Science, The Uni-
versity of Tokyo, and the animal protocols were ap-
proved by the Institutional Review Board of the insti-
tute.
LYMPHOCYTE CULTURE AND PROLIFERATION
ASSAY
OVA (grade V, Sigma-Aldrich, St. Louis, MO, USA)
was emulsified with alum by mixing 1-mgml OVA in
PBS and an equal volume of Imject AlumⓇ (Pierce,
Rockford, IL, USA). Mice were immunized intraperi-
toneally with 200 μl of 500-μgml OVA emulsified
with alum. Seven days after immunization, the spleen
and mesenteric LNs (MLNs) were collected. Spleen
and MLN cells (4 × 105 cellswell in a 96-well flat-
bottom plate) were cultured in the presence and ab-
sence of 80 μgml OVA at 37℃ for 3 days. The prolif-
erative responses of the cells were determined with a
Cell Proliferation ELISA, BrdU (chemiluminescence)
kit (Roche, Basel, Switzerland) according to the
manufacturer’s protocol.
CD4+ T cells in the spleen cells of DO11.10 mice
were purified using CD4 microbeads (BDTM IMag
Anti-Mouse CD4 Particles-DM (GK1.5), BD Pharmin-
gen, San Diego, CA, USA) according to the manufac-
turer’s protocol. CD4+ T-cell-depleted spleen cells
were used as antigen-presenting cells (APCs). DO
11.10 CD4+ T cells (1 × 106 cellswell in a 24-well
plate) were cocultured with irradiated APCs (2 × 106
cellswell) in the presence and absence of 0.05, 0.5
and 5 μM OVA323-339 peptides for 72 hours.
CYTOKINE ELISA
The cytokine levels in the culture supernatants and
bronchoalveolar lavage (BAL) fluids were deter-
mined by ELISA. Mouse IFN-γ, IL-4 and IL-10 BD Opt
EIA sets (BD Biosciences, San Diego, CA, USA),
Mouse IL-5 and IL-17 ELISA Max sets (BioLegend,
San Diego, CA, USA) and Murine IL-13 ELISA Devel-
opment Kit (PeproTech, Rocky Hill, NJ, USA) were
used. The limit of detection of ELISA was 31.3 pgml.
DC MIGRATION
FITC-conjugated OVA (FITC-OVA) was prepared,
and the levels of lung DC migration were determined
as described elsewhere.14 Briefly, mice were treated
intranasally with 100 μl of 10 mgml FITC-OVA. On
the following day, thoracic and submaxillary LNs
were collected separately, and the LN cells were incu-
bated with PE anti-mouse CD11c mAb (clone HL3,
BD Biosciences) and APC anti-mouse I-AI-E mAb
(clone M5114.15.2, eBioscience, San Diego, CA,
USA) on ice for 30 minutes after FcR blocking by ad-
dition of anti-CD16CD32 mAb (clone 93, eBi-
oscience). The proportion of FITC-positive cells in 7-
aminoactinomycin C-negative MHC class II+ CD11c+
cells was analyzed on a FACSCalibur flow cytometer
(Becton Dickinson, Franklin Lakes, NJ, USA) using
CellQuest software (Becton Dickinson).
OVA-INDUCED AIRWAY INFLAMMATION
Mice were immunized intraperitoneally with 200 μl of
500 μgml OVA emulsified with alum on days 0 and
7. The mice were then treated intranasally with 20 μl
of 10 mgml OVA in PBS or PBS alone on days 14, 15
and 16. BAL fluids were collected from naïve mice
and mice 24 hours after the last OVA or PBS inhala-
tion. The populations of BAL cells were analyzed as
described elsewhere.15,16
HISTOLOGY
Lungs were collected from naïve mice and mice 24
hours after the last OVA or PBS inhalation during
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Fig.　1　Antigen-specifi c lymphocyte responses were enhanced by Mgat5-defi ciency. Mice were immunized in-
traperitoneally with OVA emulsifi ed with alum. Seven days later, spleen and mesenteric LNs (MLNs) were col-
lected, and spleen and MLN cells were cultured in the presence and absence of 80 μg/ml OVA for 3 days. (A) 
Proliferative responses. (B) Cytokine levels in the culture supernatants. Open columns = BALB/c-wild-type (WT) 
mice; closed columns = BALB/c-Mgat5-/- mice. Data show the mean + SEM (n = 5). *p < 0.05 and **p < 0.01 vs. 
medium; and †p < 0.05 and ††p < 0.01 vs WT.
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OVA-induced airway inflammation and fixed in 10%
neutral buffered formalin. The fixed lungs were em-
bedded in paraffin, and 5-μm sections were stained
with hematoxylin and eosin (H&E) or periodic acid-
Schiff (PAS) solution.
DETECTION OF OVA-SPECIFIC Igs
Sera were collected from naïve mice and mice 24
hours after the last OVA or PBS inhalation during
OVA-induced airway inflammation. The levels of
OVA-specific IgG1, IgG2a and IgE were determined
by ELISA, as described elsewhere.15,16
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Fig.　2　Mgat5-defi ciency did not infl uence APC function. (A) Mice were treated intranasally with 
FITC-OVA. Twenty-four hours after FITC-OVA inhalation, submaxillary LNs (SL) and thoracic LNs 
(TL) were collected separately. The proportions of FITC-positive cells in 7-aminoactinomycin D-
negative MHC class II +  CD11c +  cells were determined by fl ow cytometry. Shaded area = sub-
maxillary LNs; bold lines = thoracic LNs. Representative FACS results are shown (upper panel). 
The data show the mean + SEM (lower panel). Open columns = WT mice (n = 4); closed columns = 
Mgat5-/- mice (n = 5). *p < 0.05, **p < 0.01 vs. SL. (B) CD4 +  T cells from spleens of DO11.10 mice 
were cocultured with CD4 + T-cell-depleted wild-type or Mgat5-/- spleen cells in the presence and 
absence of OVA peptides. The levels of IFN-γ and IL-10 in the culture supernatants were deter-
mined by ELISA. Data show the mean + SD (n = 3) and are representative of three independent 
experiments yielding similar results. *p < 0.05, **p < 0.01 vs. 0 (OVA323-339 peptide).
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Fig.　3　Mgat5-defi ciency results in altered profi les of infl ammatory cell infl ux in lungs during aller-
gic airway infl ammation. Mice were immunized intraperitoneally with OVA emulsifi ed with alum, 
and then challenged intranasally with OVA or PBS alone. Twenty-four hours after the last chal-
lenge, BAL fl uids were collected, and the numbers of cells therein were determined. Data show 
the mean + SEM. Open columns = WT mice (PBS, n = 8; and OVA, n = 17); closed columns = 
Mgat5-/- mice (PBS, n = 8; and OVA, n = 16). *p < 0.01 vs. PBS, †p ≤ 0.05, ††p < 0.01 vs. WT; 
and ‡p < 0.05, ‡‡p < 0.01 vs. naïve.
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STATISTICAL ANALYSES
Data show the mean with SEM or SD and were evalu-
ated for statistical significance using the two-tailed
Student’s t test or Mann-Whitney’s U-test.
RESULTS
Mgat5-DEFICIENCY RESULTS IN INCREASED
ANTIGEN-SPECIFIC IMMUNE RESPONSES In vi-
tro
It was reported that T cells from Mgat5-- mice
showed excessive Th1 cytokine production in re-
sponse to anti-TCR agonistic mAb.11 This observation
suggests that Mgat5-deficiency may also affect Th2
type immune responses. To elucidate this, Mgat5--
mice were immunized with OVA emulsified with
alum, and spleen and mesenteric LN (MLN) cells
from the mice were cultured in the presence and ab-
sence of OVA. The OVA-specific proliferative re-
sponses of spleen and MLN cells from Mgat5-- mice
were significantly increased in comparison with those
from wild-type mice (Fig. 1A). In addition, the levels
of IFN-γ and IL-10 in the culture supernatants were
increased in spleen and MLN cells from Mgat5--
mice compared with those from wild-type mice (Fig.
1B). Although the levels of IL-4 and IL-17 in MLN
cells from Mgat5-- mice seemed to be higher than
those from wild-type mice, the responses were weak,
i.e., close to the limit of detection by ELISA. The lev-
els of IL-5 and IL-13 in the culture supernatants were
increased (but not statistically significant) in MLN,
but not spleen, cells from Mgat5-- mice compared
with those from wild-type mice (Fig. 1B). The peak of
proliferation and cytokine production was at 72 hours
in our systems (data not shown).
We next examined the effect of Mgat5-deficiency
on APC function. It was shown that antigen-captured
dendritic cells (DCs), which are considered to be po-
tent APCs, migrate from local sites to draining LNs
after antigen challenge.17 After FITC-OVA inhalation,
FITC-positive MHC class II+ CD11c+ DCs were in-
creased in thoracic LNs, but not in submaxillary LNs
(Fig. 2A). The proportions of FITC-positive MHC
class II+ CD11c+ DCs in thoracic LNs were compara-
ble in wild-type and Mgat5-- mice 24 hours after
FITC-OVA inhalation (Fig. 2A). We next cocultured
OVA-specific TCR-expressing CD4+ T cells from
DO11.10 mice with or without wild-type and Mgat5--
APCs in the presence or absence of OVA peptides.
The levels of IFN-γ and IL-10 in the culture superna-
tants from DO11.10 T cells with Mgat5-- APCs were
also similar to those with wild-type APCs (Fig. 2B).
Without APCs, these cytokines were barely detect-
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Fig.　4　Pulmonary infl ammation was normally observed in Mgat5-defi cient mice during allergic airway in-
fl ammation. Twenty-four hours after the last challenge, lungs were harvested from mice as shown in Figure 3. 
(A) H&E staining and (B) PAS staining of lung sections. Data show representative results from at least 5 
mice. ×100.
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able (Fig. 2B). These observations suggest that
Mgat5-deficiency affects antigen-specific T lympho-
cyte responses rather than APC activation at least in
the tested setting.
Mgat5-DEFICIENCY RESULTS IN ALTERED
PROFILES OF INFLAMMATORY CELL INFLUX IN
LUNGS DURING ALLERGIC AIRWAY INFLAM-
MATION
Based on the in vitro study described above, Mgat5-
deficiency may contribute to the development of
antigen-specific T-cell-mediated diseases. Thus, we
next investigated the role of Mgat5 in the develop-
ment of airway inflammation induced by OVA in
Mgat5-- mice. The number of eosinophils in BAL flu-
ids was comparable between wild-type and Mgat5--
mice 24 hours after the last OVA challenge (Fig. 3).
On the other hand, the numbers of macrophages,
neutrophils and lymphocytes in BAL fluids from
Mgat5-- mice were significantly reduced compared
with wild-type mice (Fig. 3). In regard to the lung his-
tology, local inflammation was similarly observed in
wild-type and Mgat5-- mice 24 hours after the last
OVA challenge (Fig. 4), even though the numbers of
macrophages, neutrophils and lymphocytes in BAL
fluids were reduced in Mgat5-- mice, since eosino-
phils rather than the other types of cells are a major
population in the lungs of mice in that setting. The
levels of IFN-γ, IL-4, IL-5 and IL-13, but not IL-17,
were elevated in BAL fluids from OVA-challenged
mice compared with PBS-treated mice (Fig. 5). The
levels of IFN-γ, IL-4, IL-13 and IL-17 in BAL fluids
Role of Mgat5 in Murine Asthma
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Fig.　5　IL-5 levels in BAL fl uids were increased in Mgat5-defi cient mice during allergic airway infl amma-
tion. The levels of cytokines in BAL fl uids, which were collected as shown in Figure 3, were determined 
by ELISA. Data show the mean + SEM. Open columns = WT mice (PBS, n = 8; and OVA, n = 17) and 
closed columns = Mgat5-/- mice (PBS, n = 8; and OVA, n = 16). *p < 0.05, **p < 0.01 vs. PBS, †p < 0.01 
vs. WT, and ‡p < 0.05, ‡‡p < 0.01 vs. Naïve.
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were comparable in wild-type and Mgat5-- mice 24
hours after the last OVA challenge (Fig. 5). On the
other hand, the levels of IL-5 in BAL fluids from
Mgat5-- mice were significantly increased in compari-
son with wild-type mice (Fig. 5). However, the in-
creased IL-5 levels in BAL fluids did not seem to influ-
ence the number of eosinophils in Mgat5-- mice, as
shown in Figure 3. The levels of OVA-specific IgG2a
and IgE in sera were similarly increased in both
genotypes challenged with OVA in comparison with
treatment with PBS (Fig. 6). The levels of OVA-
specific IgG1 in sera were not dramatically increased,
irrespective of OVA challenge (Fig. 6), although they
were higher in Mgat5-- mice than in wild-type mice
24 hours after the last OVA challenge (Fig. 6). These
observations indicate that Mgat5-dependent protein
glycosylation can modulate immune responses, but is
not essential for the development of OVA-induced al-
lergic airway inflammation.
DISCUSSION
Mgat5-mediated glycosylation of TCR was shown to
be important for suppression of TCR-mediated T cell
activation by binding to galectin-3.10 That binding in-
duces the formation of lattice structures between
galectin-3 and TCR, thereby suppressing the forma-
tion of immuno-synapses, i.e., the engagements be-
tween TCR on T cells and MHC class II on APCs.10
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Fig.　6　OVA-specifi c serum IgG1 levels were increased in
Mgat5-defi cient mice during allergic airway infl ammation.
Twenty-four hours after the last challenge, sera were ob-
tained from mice as shown in Figure 3. The serum levels of
OVA-specifi c IgG1, IgG2a and IgE were determined by ELI-
SA. Data show the mean + SEM. Open columns = WT mice
(PBS, n = 8; OVA, n = 17; and naïve, n = 4) and closed col-
umns = Mgat5-/- mice (PBS, n = 8; OVA, n = 16; and naïve, n
= 4). *p = 0.05, **p < 0.01 vs. PBS, †p < 0.01 vs. WT; and ‡p
< 0.05, ‡‡p < 0.01 vs. naïve.
A
bs
 4
50
 n
m
 
IgG1
A
bs
 4
50
 n
m
 
IgG2a
A
bs
 4
50
 n
m
 
IgE
WT 
Mgat5-/-
PBS              OVA            Naïve
PBS              OVA             Naïve
PBS OVA Naïve
0.5
0.4
0.3
0.2
0.1
0
0.8
0.6
0.4
0.2
0
0.4
0.3
0.2
0.1
0
*
†
**
**
‡
‡‡
‡‡‡‡
‡‡
‡‡
‡‡
‡‡
‡‡
‡‡
‡‡‡‡
Thus, Mgat5-deficiency results in hyperresponsive-
ness of TCR signal transduction due to failure to form
those lattice structures between galectin-3 and TCR.10
In particular, Mgat5-- CD4+ T cells produce a larger
amount of IFN-γ, but a lesser amount of IL-4, than
wild-type CD4+ T cells after TCR-dependent stimula-
tion in vitro.11 It is thought that Th1 cells show hyper-
responsiveness to stimulation of TCR by low-affinity
antigenMHC class II complexes on APCs.18 In addi-
tion, formation of immuno-synapses is observed
when Th1 cells, but not Th2 cells, contact APCs.18,19
Such formation has not been reported between other
T cell subsets (i.e., Th17 cells, Tr1 cells and Treg
cells) and APCs. These observations suggest that
Mgat5-deficiency at least enhances Th1-type immune
responses and may thereby reciprocally regulate Th
2-type immune responses. Indeed, it was reported
that development of Th2-cytokine-mediated allergic
airway inflammation was exacerbated in IFN-γ--
mice.20 Thus, in the present study, we attempted to
elucidate the effect(s) of Mgat5-deficiency on induc-
tion of a Th2-type immune response, i.e., OVA-
induced allergic airway inflammation in Mgat5-
deficient mice. Except the number of neutrophils, no
obvious abnormality could be seen in lungs of naïve
Mgat5-- mice in comparison with those of naïve wild-
type mice (Fig. 3-5).
After OVA immunization, we found that production
of IFN-γ and IL-10, but not IL-4 or IL-17, was in-
creased in lymphocytes of Mgat5-- mice without
causing any change in APC function (Fig. 1, 2).
These observations suggest that Mgat5-- mice show
increased immune responses by Th1 cells and Tr1
Treg cells, but not Th2 cells or Th17 cells, in that set-
ting. However, Mgat5-deficiency did not affect the
number of eosinophils or the levels of IL-4 and IL-13
in BAL fluids from mice after intranasal challenge
with OVA (Fig. 3, 5), although it resulted in increased
levels of IL-5 in BAL fluids (Fig. 5). In spite of the
increased IFN-γ production by lymphocytes from
Mgat5-- mice (Fig. 1), the levels of IFN-γ in BAL flu-
ids from Mgat5-- mice were comparable with those
from wild-type mice (Fig. 5). This apparent discrep-
ancy may be due to the reduced number of lympho-
cytes in BAL fluids from Mgat5-- mice after the OVA
challenge (Fig. 5).
As is well known, IL-10 is considered to be a potent
anti-inflammatory cytokine.21 However, the role of IL-
10 in Th2 cytokine-mediated airway inflammation in
mice appears to be complicated. As in the case of in-
jection of IL-10-expressing TTreg cells,22,23 admini-
stration of recombinant IL-10 suppressed Th2 cy-
tokine production and airway eosinophilia, but en-
hanced airway hypersensitivity, during ragweed
antigen-induced airway inflammation in mice.24 The
development of Th2 cytokine-mediated airway inflam-
mation induced by OVA and ragweed antigens was
attenuated in IL-10-- mice on the C57BL6 back-
ground,25-27 suggesting that IL-10 acts as a pro-
inflammatory cytokine in that setting. Conversely,
other investigators reported that the responses in-
duced by OVA and Aspergillus fumigatus in that same
murine model were exacerbated,28-30 suggesting that
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IL-10 acts as an anti-inflammatory cytokine. In addi-
tion, IL-10-- mice on the BALBc background
showed an increased number of eosinophils in BAL
fluids, but reduced airway hypersensitivity and airway
mucus production, in airway inflammation induced by
Schistosoma egg antigens.31 Thus, these observations
suggest that increased IL-10 production by lympho-
cytes in Mgat5-- mice after sensitization with OVA
may contribute to the complicated phenotypes of pul-
monary inflammation seen in these mutant mice after
OVA challenge.
In summary, Mgat5-dependent glycosylation of
proteins regulates antigen-induced T-cell activation,
but it is not essential for the development of OVA-
induced eosinophilic airway inflammation in mice.
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